These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 21762988

  • 21. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
    Sakuma M, Shirato K.
    Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
    [Abstract] [Full Text] [Related]

  • 22. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.
    Cantrell MA, Baye J, Vouri SM.
    Pharmacotherapy; 2013 Jun 28; 33(6):639-49. PubMed ID: 23529917
    [Abstract] [Full Text] [Related]

  • 25. Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension.
    Hori Y, Kondo C, Matsui M, Yamagishi M, Okano S, Chikazawa S, Kanai K, Hoshi F, Itoh N.
    Vet J; 2014 Nov 28; 202(2):334-9. PubMed ID: 25178687
    [Abstract] [Full Text] [Related]

  • 26. Safety and long-term efficacy of transition from sildenafil to tadalafil due to side effects in patients with pulmonary arterial hypertension.
    Lichtblau M, Harzheim D, Ehlken N, Marra A, Pinado FP, Grünig E, Egenlauf B.
    Lung; 2015 Feb 28; 193(1):105-12. PubMed ID: 25318865
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR, Lipworth BJ, Hopkinson PJ, Wei L, Struthers AD.
    Lancet Respir Med; 2014 Apr 28; 2(4):293-300. PubMed ID: 24717626
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
    Chaumais MC, Perrin S, Sitbon O, Simonneau G, Humbert M, Montani D.
    Expert Opin Drug Metab Toxicol; 2013 Sep 28; 9(9):1193-205. PubMed ID: 23944387
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tadalafil improves oxygenation in a model of newborn pulmonary hypertension.
    Tessler RB, Zadinello M, Fiori H, Colvero M, Belik J, Fiori RM.
    Pediatr Crit Care Med; 2008 May 28; 9(3):330-2. PubMed ID: 18446109
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.
    BJU Int; 2004 Oct 28; 94(6):871-7. PubMed ID: 15476525
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA.
    Am J Cardiol; 2005 Dec 26; 96(12B):42M-46M. PubMed ID: 16387566
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U, Gleiter CH.
    Eur J Med Res; 2002 Oct 29; 7(10):435-46. PubMed ID: 12435622
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.
    Eur Urol; 2004 Sep 29; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.